Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
In a pivotal decision on June 13, 2013, the U.S. Supreme Court struck down patents on the BRCA1 and BRCA2 genes, which are linked to hereditary breast and ovarian cancer. The ruling followed a lawsuit initiated by the American Civil Liberties Union (ACLU) and the Public Patent Foundation (PUBPAT) on behalf of a broad…
Share This Article
Ready-to-post copy includes the article link.
Supreme Court Rules Against Patenting of BRCA1 and BRCA2 Genes in Landmark ACLU Case In a pivotal decision on June 13, 2013, the U.S. Supreme Court struck down patents on the BRCA1 and BRCA2 genes, which are linked to hereditary breast and ovarian cancer. The ruling followed a lawsuit initiated by the A... Read the full IIPLA article: https://iipla.org/news/supreme-court-rules-against-patenting-of-brca1-and-brca2-genes-in-landmark-aclu-case